BROADFOOT JILL MARIE (Chief Financial Officer) purchased 21.8% of their position (5K shares) of ATYR PHARMA INC on the open market
Open‑market purchase worth $8.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/3/2024ACC: 0000950170-24-067668
Officer· Chief Financial Officer
Since Jul 2018
+5K
Net shares
Net buyer
$8.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$1.79
Trade value
$8.95K
% of position
21.8%
5/31/2024
22.96K→27.96K
Total
Net shares
+5K
Net value
$8.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2024 | P · Purchase | +5K | $1.79 | $8.95K | 21.8% | 22.96K | 27.96K |
| Total | +5K | $8.95K | ||||||
Derivative Transactions0
No derivative transactions reported